Quick Answer
Nuvectis Pharma, Inc. reported Shares Outstanding of 25.68 million shares for fiscal year 2025.
Nuvectis Pharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 25.68M | +31.7% |
| 2024 | 19.50M | +11.9% |
| 2023 | 17.42M | +14.7% |
| 2022 | 15.19M | +237.2% |
| 2021 | 4.51M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 25.64M | +35.1% | +7.4% |
| June 30, 2025 | 23.88M | +27.4% | +1.0% |
| March 31, 2025 | 23.63M | +28.8% | +21.2% |
| December 31, 2024 | 19.50M | +11.9% | +2.7% |
| September 30, 2024 | 18.99M | +9.7% | +1.3% |
| June 30, 2024 | 18.75M | +8.9% | +2.1% |
| March 31, 2024 | 18.36M | — | +5.4% |
| December 31, 2023 | 17.42M | +14.7% | +0.6% |
- Nuvectis Pharma, Inc. showed an increase of +31.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Nuvectis Pharma, Inc.’s shares outstanding has grown by 469.9% (from 4.51 million shares to 25.68 million shares).
- The most recent figure is from Nuvectis Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: